Compare PKE & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKE | ANGO |
|---|---|---|
| Founded | 1954 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.4M | 400.8M |
| IPO Year | N/A | 2004 |
| Metric | PKE | ANGO |
|---|---|---|
| Price | $21.04 | $13.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 94.9K | ★ 475.4K |
| Earning Date | 01-13-2026 | 01-07-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 5.81 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | $63,128,000.00 | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $56.98 | ★ N/A |
| Revenue Growth | ★ 7.63 | 2.73 |
| 52 Week Low | $11.97 | $8.27 |
| 52 Week High | $21.52 | $13.99 |
| Indicator | PKE | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 64.46 | 59.17 |
| Support Level | $19.84 | $13.12 |
| Resistance Level | $20.99 | $13.70 |
| Average True Range (ATR) | 0.69 | 0.38 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 99.60 | 40.09 |
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.